Pictet Asset Management (Switzerland)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$79M Buy
177,752
+7,406
+4% +$3.42M 0.09% 223
2023
Q1
$78.3M Buy
170,346
+54,061
+46% +$25.7M 0.1% 230
2022
Q4
$59.7M Buy
116,285
+1,990
+2% +$1.01M 0.09% 245
2022
Q3
$51.9M Sell
114,295
-1,440
-1% -$689K 0.08% 259
2022
Q2
$55.9M Buy
115,735
+14,310
+14% +$7.08M 0.08% 266
2022
Q1
$49.8M Buy
101,425
+1,478
+1% +$676K 0.06% 309
2021
Q4
$46.3M Sell
99,947
-1,043
-1% -$439K 0.05% 353
2021
Q3
$37.6M Buy
+100,990
New +$38.4M 0.04% 392

Other funds holding ELV

Pictet Asset Management (Switzerland)'s ELV Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Elevance Health (ELV) stake by 4.3% in Q2 2023, buying an estimated $3.42M and bringing the position to 177,752 shares worth $79M. The position accounts for 0.09% of the portfolio, ranked #223.

Pictet Asset Management (Switzerland) first reported a position in ELV in Q3 2021 and has held it in 8 quarters since. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 177,752 shares of Elevance Health worth $79M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 7,406 Elevance Health shares in Q2 2023, an estimated $3.42M.
  • Elevance Health made up 0.09% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #223 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Elevance Health in Q3 2021 and has held it in 8 quarters since.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.